Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
株式のランク #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
株価
$0.49606484
最終同期: 2026-08-21
時価総額
$88.47M
変化(1日)
-1.58%
変化(1年)
-22.51%
TW
取引 Intech Biopharm Corporation (6461)

カテゴリー

Intech Biopharm Corporation(6461)の配当利回りの履歴
Intech Biopharm Corporation(銘柄コード: 6461)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Intech Biopharm Corporation(6461)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)